Cargando…

Induction Chemotherapy and Ablative Stereotactic Magnetic Resonance Image-Guided Adaptive Radiation Therapy for Inoperable Pancreas Cancer

BACKGROUND: Radiation therapy (RT) dose for inoperable pancreatic ductal adenocarcinoma (PDAC) has historically been non-ablative to avoid injuring gastrointestinal (GI) organs at risk (OARs). Accruing data suggest that dose escalation, in select patients, may significantly improve clinical outcomes...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chuong, Michael D., Herrera, Roberto, Kaiser, Adeel, Rubens, Muni, Romaguera, Tino, Alvarez, Diane, Kotecha, Rupesh, Hall, Matthew D., McCulloch, James, Ucar, Antonio, DeZarraga, Fernando, Aparo, Santiago, Joseph, Sarah, Asbun, Horacio, Jimenez, Ramon, Narayanan, Govindarajan, Gutierrez, Alonso N., Mittauer, Kathryn E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9259801/ https://www.ncbi.nlm.nih.gov/pubmed/35814383 http://dx.doi.org/10.3389/fonc.2022.888462

Ejemplares similares

Causes of Death Among Patients With Initially Inoperable Pancreas Cancer After Induction Chemotherapy and Ablative 5-fraction Stereotactic Magnetic Resonance Image Guided Adaptive Radiation Therapy
por: Chuong, Michael D., et al.
Publicado: (2022)

Dose-Escalated Magnetic Resonance Image–Guided Abdominopelvic Reirradiation With Continuous Intrafraction Visualization, Soft Tissue Tracking, and Automatic Beam Gating
por: Chuong, Michael D., et al.
Publicado: (2021)

Multi-Institutional Outcomes of Stereotactic Magnetic Resonance Image Guided Adaptive Radiation Therapy With a Median Biologically Effective Dose of 100 Gy(10) for Non-bone Oligometastases
por: Kutuk, Tugce, et al.
Publicado: (2022)

Multi-Institutional Outcomes of Patients Aged 75 years and Older With Pancreatic Ductal Adenocarcinoma Treated With 5-Fraction Ablative Stereotactic Magnetic Resonance Image-Guided Adaptive Radiation Therapy (A-SMART)
por: Bryant, JM, et al.
Publicado: (2023)

Stereotactic radiosurgery for non-functioning pituitary adenomas: meta-analysis and International Stereotactic Radiosurgery Society practice opinion
por: Kotecha, Rupesh, et al.
Publicado: (2020)

Pembrolizumab activity in patients with Fanconi anemia repair pathway competent and deficient tumors
por: Villalona-Calero, Miguel A., et al.
Publicado: (2022)

Ablative 5-Fraction Stereotactic MRI-Guided Adaptive Radiotherapy for Oligometastatic Pancreatic Adenocarcinoma
por: Webking, Samantha, et al.
Publicado: (2023)

Emerging Evidence on the Effects of Dietary Factors on the Gut Microbiome in Colorectal Cancer
por: Appunni, Sandeep, et al.
Publicado: (2021)

Initial clinical experience with magnetic resonance-guided radiotherapy in pediatric patients: Lessons learned from a single institution with proton therapy
por: Hall, Matthew D., et al.
Publicado: (2023)

Early-onset symptomatic radiation necrosis after stereotactic radiosurgery in the setting of COVID-19 infection
por: Weltman, Eduardo, et al.
Publicado: (2021)

Editorial: Novel Applications of Stereotactic Body Radiotherapy (SBRT)
por: Kotecha, Rupesh, et al.
Publicado: (2021)

33. SYSTEMATIC REVIEW AND META-ANALYSIS OF BREAST CANCER BRAIN METASTASIS AND PRIMARY TUMOR RECEPTOR EXPRESSION DISCORDANCE
por: Kotecha, Rupesh, et al.
Publicado: (2020)

Hospitalization rates from radiotherapy complications in the United States
por: Tonse, Raees, et al.
Publicado: (2022)

SPIN-01 RADIATION THERAPY ALONE VERSUS RADIATION THERAPY PLUS RADIOFREQUENCY ABLATION/VERTEBRAL AUGMENTATION FOR SPINE METASTASIS: TRIAL IN PROGRESS
por: Kotecha, Rupesh, et al.
Publicado: (2022)

Medically inoperable peripheral lung cancer treated with stereotactic body radiation therapy
por: Kelley, K. D., et al.
Publicado: (2015)

Relationship between insurance status and interhospital transfers among cancer patients in the United States
por: Rubens, Muni, et al.
Publicado: (2022)

Hospitalization rates for complications due to systemic therapy in the United States
por: Saxena, Anshul, et al.
Publicado: (2021)

Systematic review and meta-analysis of breast cancer brain metastasis and primary tumor receptor expression discordance
por: Kotecha, Rupesh, et al.
Publicado: (2021)

Integration of Systemic Therapy and Stereotactic Radiosurgery for Brain Metastases
por: Tonse, Raees, et al.
Publicado: (2021)

Erratum to: Stereotactic targeted radiation therapy (STaRT) trials for brain neoplasms: A comprehensive review
por: Odia, Yazmin, et al.
Publicado: (2022)

Total pancreatectomy: Short- and long-term outcomes at a high-volume pancreas center
por: Zakaria, Hazem M, et al.
Publicado: (2016)

Stereotactic Body Radiotherapy for Inoperable Liver Tumors: Results of a Single Institutional Experience
por: Hijazi, Hussam, et al.
Publicado: (2016)

Effectiveness of Stereotactic Ablative Radiotherapy for Systemic Therapy Respondents with Inoperable Pulmonary Oligometastases and Oligoprogression
por: Ho, Chin-Beng, et al.
Publicado: (2023)

NEIM-02 CHARACTERIZATION OF LARGE BRAIN METASTASES WITH(18)F-FLUCICLOVINE PET/CT TREATED WITH STAGED STEREOTACTIC RADIOSURGERY (SSRS): INTERIM ANALYSIS OF A PILOT STUDY
por: Rosa, Alonso La, et al.
Publicado: (2023)

Stereotactic Body Radiotherapy as Primary Treatment for Elderly Patients with Medically Inoperable Head and Neck Cancer
por: Vargo, John A., et al.
Publicado: (2014)

Stereotactic body radiation therapy for palliative management of pancreatic adenocarcinoma in elderly and medically inoperable patients
por: Ryan, John F., et al.
Publicado: (2018)

Impact of tumor size on outcome after stereotactic body radiation therapy for inoperable hepatocellular carcinoma
por: Kuo, Hsing-Tao, et al.
Publicado: (2017)

A retrospective study on unresectable or inoperable head and neck cancers treated with stereotactic ablative brachytherapy
por: Zhao, Genghao, et al.
Publicado: (2022)

Magnetic Resonance Imaging-Guided Stereotactic Body Radiation Therapy for Medically Inoperable Endometrial Cancer
por: Dincer, Neris, et al.
Publicado: (2023)

Prognostic value of CA 19-9 levels in patients with inoperable adenocarcinoma of the pancreas treated with gemcitabine
por: Ziske, C, et al.
Publicado: (2003)

Meta-Analysis of Survival and Development of a Prognostic Nomogram for Malignant Pleural Mesothelioma Treated with Systemic Chemotherapy
por: Kotecha, Rupesh, et al.
Publicado: (2021)

Cost-utility of stereotactic radiation therapy versus proton beam therapy for inoperable advanced hepatocellular carcinoma
por: Leung, Henry W.C., et al.
Publicado: (2017)

Prognostic role of stereotactic body radiation therapy for elderly patients with advanced and medically inoperable pancreatic cancer
por: Zhu, Xiaofei, et al.
Publicado: (2017)

Hypofractionation and Stereotactic Body Radiation Therapy in Inoperable Locally Advanced Non-small Cell Lung Cancer
por: Rico, Mikel, et al.
Publicado: (2021)

Are serial measurements of CA19-9 useful in predicting response to chemotherapy in patients with inoperable adenocarcinoma of the pancreas?
por: Gogas, H., et al.
Publicado: (1998)

RONC-08. SURVIVAL IMPACT OF POSTOPERATIVE RADIOTHERAPY TIMING IN PEDIATRIC AND YOUNG ADULT EPENDYMOMA
por: Shah, Sunny, et al.
Publicado: (2020)

Inoperable Cancer
Publicado: (1901)

Stereotactic Ablative Radiotherapy (SABR) in inoperable oligometastatic disease from colorectal cancer: a safe and effective approach
por: Comito, Tiziana, et al.
Publicado: (2014)

Radiosensitizing Chemotherapy (Irinotecan) with Stereotactic Body Radiation Therapy for the Treatment of Inoperable Liver and/or Lung Metastases of Colorectal Cancer
por: Vaugier, Loïg, et al.
Publicado: (2021)

Stereotactic ablative radiotherapy for inoperable T1‐2N0M0 small‐cell lung cancer
por: Tang, Hui, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_b4bbnaom60i6j1l37q9fivmp18